Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 2
is this a disappointing update in that the NDA approval has not been moved to a sooner date?

A quarter off, meh. The FDA had been pushing things through pretty quickly and ahead of schedule so there is still hope? I wonder if the covid card could/would/will be played, though I suspect TCDA is above that. Specifically, one could argue that hey, with this medication a slew of potentially higher risk folks don't have to start dialysis and don't have to potentially be near a large gathering of other at risk people.

Not sure how I feel about plowing forward and don't recall what the CEO did with his other renal drug companies that were one trick ponies. Not sure if it means they're really holding out for a big payday or what. I can't imagine the plan all along was to create a functional company that would mature into a profitable business with a pipeline long term, but this drug certainly seems capable of selling more annually than this companies current market cap. I've bought 3 times this year in my retirement account and it's 4.5% of my port right now... So I'm not too worried about the investment.
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.